Weekly Buzz: So far, Santa is Letting us Down

Kevin Travers16:59 ET

Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock

Kevin TraversDec 27 10:52 ET

3 Healthcare Stocks to Buy for a 2025 Rebound

Barron'sDec 27 02:00 ET

Novo-Nordisk A/S faces another blow: Musk shares a weight loss photo, claiming that using Eli Lilly and Co's weight loss drug is more effective than semaglutide.

On Christmas, Musk shared a photo and called himself the Ozempic Santa Claus, clarifying that he didn't mean the drug name Ozempic for semaglutide, but rather Eli Lilly and Co's competitor Mounjaro. He also mentioned that "high doses" of Ozempic would make him fart and burp, adding that "Mounjaro seems to have fewer side effects and is more effective."

wallstreetcnDec 26 17:04 ET

Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?

BenzingaDec 26 14:25 ET

Musk revealed that he switched to using Eli Lilly and Co's weight loss medication: the effect is better than Novo-Nordisk A/S's competing products, with fewer side effects.

① The world's richest man Elon Musk confirmed on the Social Media platform X on Wednesday that he is using Eli Lilly and Co's Mounjaro for weight loss; ② Musk revealed that he initially tried using Novo-Nordisk A/S's Ozempic for weight loss, but switched to Mounjaro due to significant side effects.

cls.cnDec 26 12:55 ET